Key points are not available for this paper at this time.
Suppl Table S1. Clinical characteristics of metastatic patient cohort Suppl Table S2. The 361 gene signature identified in this study to classify T-cell immune clusters Suppl Table S3. The 80 immune and stroma related gene signatures used to quantify the TME Suppl Table S4. DEGs for SCLC versus NEPC tumors Suppl Table S5. NCI-Nature₂016 pathways enriched in the DEGs from SCLC vs NEPC
Bhinder et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: